logo-loader
viewPredictmedix Inc.

PredictMedix files two U.S. patents for technology while seeing big growth potential in Europe

PredictMedix (CSE: PMED- OTCQB: PMEDF) CEO Dr Rahul Kushwah, Thomas Loftus, Director with Taurus Medical Solutions, and Dr Arun Chauhan with Vital healthcare Group joined Steve Darling from Proactive to a number of issues.

Dr Kushwah shared with Proactive that the company has filed two patents in the United States and is also starting to look at Europe to further grow their client base. Both Loftus and Chauhan talk about what they like about the technology and how it can be rolled out across the UK and all of Europe.

Quick facts: Predictmedix Inc.

Price: 0.83 CAD

CSE:PMED
Market: CSE
Market Cap: $83.04 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Predictmedix Inc. named herein, including the promotion by the Company of Predictmedix Inc. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Predictmedix signs with fortune 500 company Tech Mahindra to use impairment...

Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive Vancouver to discuss the company signing a deal with mega company Tech Mahindra. Kushwah discusses their impairment technology and how Tech Mahindra will be utilising it going forward.

on 26/6/20

2 min read